In a new study that was presented at the 2018 ASCO Annual Meeting, researchers investigated the prevalence of venous thromboembolism in patients with various types of hematologic malignancies, as well as...
In a recent study, researchers evaluated the safety and efficacy of a certain chimeric antigen receptor–modified T cell therapy in patients with chronic lymphocytic leukemia. To see results of the study,...
